Incyte Corp (NASDAQ:INCY)

CAPS Rating: 3 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar ayuddha (< 20) Submitted: 7/15/2012 5:18:50 PM : Outperform Start Price: $25.50 INCY Score: -32.90

It was picked by www.hechtsoft.de Trade Alerts.

Featured Broker Partners


Advertisement